Robert Lechleider, Chief Medical Officer at Immunome Inc. (IMNM), sold 55,000 shares at $19.56 ($1.1M) on 2026-06-25, disclosed to the SEC on 2026-06-29.
Scheduled sale ($1.1M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.56 | 40,580 | $794K | 72.7% |
| 2 | $20.66 | 14,420 | $298K | 27.3% |
| Total | $19.85 avg | 55,000 | $1.1M | 100% |
| Filing → |